Adams Brian bought KYMR
September 3, 2025 · Form 4 insider transaction
Adams Brian bought 52,500 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
52,500
Price
$0.00
Total value
N/A
InsiderAdams Brian
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2025
Filing dateSeptember 3, 2025
Shares owned after52,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following September 3, 2025, subject to the reporting person's continued employment through each vesting date.